Erkko Ylösmäki

1.5k citations
27 papers · 1.0k indexed · h-index 18
Topics
Virus-based gene therapy research (14 papers)CAR-T cell therapy research (12 papers)Immunotherapy and Immune Responses (12 papers)
Partner nations
FinlandItalySweden

In The Last Decade

Erkko Ylösmäki

27 papers receiving 996 citations

Peers

Erkko Ylösmäki
Comparison fields: 5 of 73
  • Molecular Biology 514
  • Genetics 391
  • Oncology 353
  • Biotechnology 269
  • Immunology 260
Replace Markus Wolschek with:
Markus Wolschek Austria
G. Simons Netherlands
Maureen Thornton United States
David Ruano‐Gallego Spain
Ahmet Civas France
Kathrin Westphal Germany
Otto-Wilhelm Merten France
Annie Findeli France
Say Kong Ng Singapore
William J.J. Finlay United States
Erkko Ylösmäki relative to Markus Wolschek Austria Markus Wolschek's profile →
Citations per field
00.5×4.8×
Markus Wolschek · 1×
Citations per year

Countries citing papers authored by Erkko Ylösmäki

Since Specialization
Citations

This map shows the geographic impact of Erkko Ylösmäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkko Ylösmäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkko Ylösmäki more than expected).

Fields of papers citing papers by Erkko Ylösmäki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkko Ylösmäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkko Ylösmäki. The network helps show where Erkko Ylösmäki may publish in the future.

Co-authorship network of co-authors of Erkko Ylösmäki

This figure shows the co-authorship network connecting the top 25 collaborators of Erkko Ylösmäki. A scholar is included among the top collaborators of Erkko Ylösmäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkko Ylösmäki. Erkko Ylösmäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 14
4 26
5 22
6 17
7 25
8 37
9 8
10 45
11 40
12 97
13 7
14 104
15 40
16 39
17 3
18 6
19 10
20 24

About Erkko Ylösmäki

Erkko Ylösmäki is a scholar working on Immunology, Genetics and Oncology, having authored 27 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Biotechnology (269 citations), Genetics (391 citations) and Oncology (353 citations). Erkko Ylösmäki has collaborated with scholars based in Finland, Italy and Sweden. Frequent co-authors include Vincenzo Cerullo, Markku Saloheimo, Sara Feola, Kalle Saksela, Kristiina Kruus, Matti Siika‐aho, Laura-Leena Kiiskinen, Michael Bailey, Juha Kuja‐Panula and Michael P. Ward. Their work appears in journals such as Nature Communications, PLoS ONE and Applied and Environmental Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026